269 related articles for article (PubMed ID: 31108228)
21. The Population-Based Long-Term Impact of Anticoagulant and Antiplatelet Therapies in Low-Risk Patients With Atrial Fibrillation.
Golive A; May HT; Bair TL; Jacobs V; Crandall BG; Cutler MJ; Day JD; Mallender C; Osborn JS; Stevens SM; Weiss JP; Woller SC; Bunch TJ
Am J Cardiol; 2017 Jul; 120(1):75-82. PubMed ID: 28483209
[TBL] [Abstract][Full Text] [Related]
22. Gastrointestinal bleeding in patients with atrial fibrillation treated with Apixaban or warfarin: Insights from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial.
Garcia DA; Fisher DA; Mulder H; Wruck L; De Caterina R; Halvorsen S; Granger CB; Held C; Wallentin L; Alexander JH; Lopes RD
Am Heart J; 2020 Mar; 221():1-8. PubMed ID: 31896036
[TBL] [Abstract][Full Text] [Related]
23. Frequency, Trend, Predictors, and Impact of Gastrointestinal Bleeding in Atrial Fibrillation Hospitalizations.
Dave M; Kumar A; Majmundar M; Adalja D; Shariff M; Shah P; Desai R; Patel K; Jagirdhar GSK; Vallabhajosyula S; Gullapalli N; Doshi R
Am J Cardiol; 2021 May; 146():29-35. PubMed ID: 33529616
[TBL] [Abstract][Full Text] [Related]
24. Residential medication management reviews of antithrombotic therapy in aged care residents with atrial fibrillation: assessment of stroke and bleeding risk.
Nishtala PS; Castelino RL; Peterson GM; Hannan PJ; Salahudeen MS
J Clin Pharm Ther; 2016 Jun; 41(3):279-84. PubMed ID: 27062272
[TBL] [Abstract][Full Text] [Related]
25. Antithrombotic therapy and outcomes after ICD implantation in patients with atrial fibrillation and coronary artery disease: an analysis from the National Cardiovascular Data Registry (NCDR)®.
Ghanbari H; Nallamothu BK; Wang Y; Curtis JP
J Am Heart Assoc; 2015 Jan; 4(2):. PubMed ID: 25637345
[TBL] [Abstract][Full Text] [Related]
26. Triple vs Dual Antithrombotic Therapy in Patients with Atrial Fibrillation and Coronary Artery Disease.
Lopes RD; Rao M; Simon DN; Thomas L; Ansell J; Fonarow GC; Gersh BJ; Go AS; Hylek EM; Kowey P; Piccini JP; Singer DE; Chang P; Peterson ED; Mahaffey KW
Am J Med; 2016 Jun; 129(6):592-599.e1. PubMed ID: 26797080
[TBL] [Abstract][Full Text] [Related]
27. Antithrombotic Medication and the Risk of Vitreous Hemorrhage in Atrial Fibrillation: Korean National Health Insurance Service National Cohort.
Kim KE; Yang PS; Jang E; Kim S; Joung B
Yonsei Med J; 2019 Jan; 60(1):65-72. PubMed ID: 30554492
[TBL] [Abstract][Full Text] [Related]
28. Risk profiles and pattern of antithrombotic use in patients with non-valvular atrial fibrillation in Thailand: a multicenter study.
Krittayaphong R; Winijkul A; Methavigul K; Wongtheptien W; Wongvipaporn C; Wisaratapong T; Kunjara-Na-Ayudhya R; Boonyaratvej S; Komoltri C; Kaewcomdee P; Yindeengam A; Sritara P;
BMC Cardiovasc Disord; 2018 Aug; 18(1):174. PubMed ID: 30144802
[TBL] [Abstract][Full Text] [Related]
29. Warfarin and Antiplatelet Therapy Versus Warfarin Alone for Treating Patients With Atrial Fibrillation Undergoing Transcatheter Aortic Valve Replacement.
Abdul-Jawad Altisent O; Durand E; Muñoz-García AJ; Nombela-Franco L; Cheema A; Kefer J; Gutierrez E; Benítez LM; Amat-Santos IJ; Serra V; Eltchaninoff H; Alnasser SM; Elízaga J; Dager A; García Del Blanco B; Ortas-Nadal Mdel R; Marsal JR; Campelo-Parada F; Regueiro A; Del Trigo M; Dumont E; Puri R; Rodés-Cabau J
JACC Cardiovasc Interv; 2016 Aug; 9(16):1706-17. PubMed ID: 27539691
[TBL] [Abstract][Full Text] [Related]
30. The Combination of Oral Anticoagulant and Antiplatelet Therapies: Stay One Step Ahead.
Lucà F; Giubilato S; Fusco SAD; Leone A; Poli S; Rao CM; Iorio A; Gelsomino S; Gabrielli D; Colivicchi F; De Luca L; Gulizia MM
J Cardiovasc Pharmacol Ther; 2020 Sep; 25(5):391-398. PubMed ID: 32390532
[TBL] [Abstract][Full Text] [Related]
31. Antithrombotic and anticoagulant therapy for atrial fibrillation.
Dzeshka MS; Lip GY
Cardiol Clin; 2014 Nov; 32(4):585-99. PubMed ID: 25443239
[TBL] [Abstract][Full Text] [Related]
32. Risk of Bleeding Associated With Nonsteroidal Anti-inflammatory Drug Use in Patients Exposed to Antithrombotic Therapy: A Case-Crossover Study.
Paternoster M; Steichen O; Lapeyre-Mestre M; Blanchon T; Rossignol L; Vilcu AM; Launay T; Sarazin M; Bagheri H; Conte C; Turbelin C; Hanslik T; Souty C
J Clin Pharmacol; 2022 May; 62(5):636-645. PubMed ID: 34787325
[TBL] [Abstract][Full Text] [Related]
33. Antithrombotic Therapy in Patients With Atrial Fibrillation and Coronary Artery Disease Undergoing Percutaneous Coronary Intervention.
Mishra A; Singh M; Acker WW; Kamboj S; Sporn D; Stapleton D; Kaluski E
J Cardiovasc Pharmacol; 2019 Aug; 74(2):82-90. PubMed ID: 31306367
[TBL] [Abstract][Full Text] [Related]
34. Clinical impact of gastrointestinal bleeding in patients undergoing percutaneous coronary interventions.
Koskinas KC; Räber L; Zanchin T; Wenaweser P; Stortecky S; Moschovitis A; Khattab AA; Pilgrim T; Blöchlinger S; Moro C; Jüni P; Meier B; Heg D; Windecker S
Circ Cardiovasc Interv; 2015 May; 8(5):. PubMed ID: 25910501
[TBL] [Abstract][Full Text] [Related]
35. Antithrombotic Treatment Following Intracerebral Hemorrhage in Patients With and Without Atrial Fibrillation.
Pennlert J; Asplund K; Carlberg B; Wiklund PG; Wisten A; Åsberg S; Eriksson M
Stroke; 2015 Aug; 46(8):2094-9. PubMed ID: 26159794
[TBL] [Abstract][Full Text] [Related]
36. Gastrointestinal bleeding in patients with acute coronary syndromes: incidence, predictors, and clinical implications: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial.
Nikolsky E; Stone GW; Kirtane AJ; Dangas GD; Lansky AJ; McLaurin B; Lincoff AM; Feit F; Moses JW; Fahy M; Manoukian SV; White HD; Ohman EM; Bertrand ME; Cox DA; Mehran R
J Am Coll Cardiol; 2009 Sep; 54(14):1293-302. PubMed ID: 19778672
[TBL] [Abstract][Full Text] [Related]
37. The Tasmanian atrial fibrillation study: Transition to direct oral anticoagulants 2011-2015.
Alamneh EA; Chalmers L; Bereznicki LR
Cardiovasc Ther; 2017 Jun; 35(3):. PubMed ID: 28177198
[TBL] [Abstract][Full Text] [Related]
38. Restarting Anticoagulant Treatment After Intracranial Hemorrhage in Patients With Atrial Fibrillation and the Impact on Recurrent Stroke, Mortality, and Bleeding: A Nationwide Cohort Study.
Nielsen PB; Larsen TB; Skjøth F; Gorst-Rasmussen A; Rasmussen LH; Lip GY
Circulation; 2015 Aug; 132(6):517-25. PubMed ID: 26059010
[TBL] [Abstract][Full Text] [Related]
39. Gastrointestinal bleeding associated with antithrombotic therapy in the elderly in Japan.
Suehiro T; Yakeishi Y; Sakai F; Matsuzaki K; Sanefuji K; Toyokawa T; Shioshita K; Sugie Y; Okudaira Y; Kano T; Mine H; Suetsugu K; Suetsugu F; Suehiro N; Suhiro K
Hepatogastroenterology; 2012 May; 59(115):774-7. PubMed ID: 22469720
[TBL] [Abstract][Full Text] [Related]
40. Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention: A North American Perspective-2018 Update.
Angiolillo DJ; Goodman SG; Bhatt DL; Eikelboom JW; Price MJ; Moliterno DJ; Cannon CP; Tanguay JF; Granger CB; Mauri L; Holmes DR; Gibson CM; Faxon DP
Circulation; 2018 Jul; 138(5):527-536. PubMed ID: 30571525
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]